The molecular mechanisms of term and preterm labor: Recent progress and clinical implications

Clinical Obstetrics and Gynecology

Volumn 40, Issue 3, 1997, Pages 460-478

  Keelan, Jeffrey A ^a   Coleman, Matthew ^b   Mitchell, Murray D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID;

GAP JUNCTION; HUMAN; LABOR; LABOR COMPLICATION; MYOMETRIUM; NEW ZEALAND; PREMATURE LABOR; PROSTAGLANDIN SYNTHESIS; REVIEW; UTERUS CONTRACTILITY;

FEMALE; HUMANS; LABOR ONSET; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYSIS;

EID: 0031407012     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199709000-00004     Document Type: Review

References (83)

1. Burghardt RC, Barhoumi R, Dookwah H. Endocrine regulation of myometrial gap junctions and their role in parturition. Semin Reprod Endocrinol. 1993;11:250-260.
2. Lye SJ. The initiation and inhibition of la- bour: toward a molecular understanding, Semin Reprod Endocrinol. 1994;12:284-297.
3. Orsino A, Taylor CV, Lye SJ. Connexin- 26 and connexin-43 are differentially expressed and regulated in the rat myometrium throughout late pegnance and with the onset of labor. Endocrinology. 1996;137:1545-1553.
4. Wendelberger KJ. Prostaglandin and leukotriene receptors in pulmonary, vascular, and uterine smooth muscle. Semin Perinatol. 1987;11:1-11.
5. Chegini N, Rao CV. The presence of leuko- triene C4-and porostacyclin-binding sites in nonpregnant human uterine tissue. J Clin Endocrinol Metab. 1988;66:76-87.
6. Myatt L, Moore SD. Myometrium and preterm labour: steroids and prostaglandins. Semin Reprod Endocrinol 1994;12:298-313.
7. Hirst JJ, Chibbar R, Mitchell BF. Role of oxytocin in the regulation of uterine activity during pregnancy and in the initiation of labour. Semin Reprod Endocrinol 1993;11:221-233.
8. Fuchs A-R, Fuchs F, Husslein P, et al. A dual role for oxytocin in the initiation of labor. Science. 1982;215:1396-1398.
9. Takemura M, Kimura T, Nomura S, et al. Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition. J Clin Invest. 1994;93:2319-2323.
10. Valenzuela GJ, Hewitt CW and Ducsay CA. Endothelin -I potentiates the in vitro contractile response of pregnant human myometrium to oxytocin. Am J Obstet Gynecol 1995;172:1573-1576.
11. s protein isoforms in pregnancy and their down-regulation during labor. J Clin Endocrinol Metab. 1996;81:1069-1075.
12. Hillhouse EW, Grammatopoulos D, Milton NGN, et al. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab. 1993;78:736-741.
13. Quartero HWP, Noort WA, Fry CH, et al. Role of prostaglandis and leukotienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins. 1991;42:137-150.
14. Schiff E, Ben-Baruch G, Galron R, et al. Endothelin-1 receptors in the human myometrium: evidence for differnet binding properties in postmenopausal as compared to postmenopausal and pregnant women. Clin Endocrinol. 1993;38:321-324.
15. Peri A, Vennelli GB, Fantoni G, et al. Endothelin in rabbit uterus during pregnance. Am J Physiol. 1992;263:E158-167.
16. Izumi H, Byam-Smith M, Garfield RE. Gestational changes in oxytocin- and endi- thelin-induced contractility of pregnant rat myometrium. Eur J Phamacol. 1995;278:187-194.
17. Maggi M, Vannelli GB, Fantoni G, et al. Endothelin in the human uterus during pregnancy. J Endocrinol. 1994;142:385-396.
18. a. J Clin Endocrinol Metab.1992;75:1027-1032.
19. Buhimschi I, Yallampalli C, Dong YL, et al. Involvement of a nitric oxide-cyclic guanosine monophoosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol. 1995;172:1577-1584.
20. Liggins GC. Initiation of spontaneous labor. Clin Obstet Gynecol. 1983;26:47-54.
21. Thiery M. Induction of labour with prosta- glandins. In: Keirse MJNC, Anderson ABM, Bennebroek-Gravenhorst J, eds. Human Parturition. The Hague: Martinus Nijhoff, 1979:155-164.
22. Olson DM, Zakar T, Mitchell BF. Prostaglandin synthesis regulation by intrauterine tissues. In: GE Rice, SP Brennecke, eds. Molecular Aspects of Placental and Fetal Autocoids. London: CRC Press, 1993;54-95.
23. 2 in the initiation of human parturition. J Clin Endocrinol Metab. 1993;76:1332-1339.
24. Romero R, Baumann P, Gonzales R, et al. Amniotic fluid prostanoid concentrations increase early during the course of spontaneous labor at term. Am J Obstet Gynecol. 1994;171:1613-1620.
25. Rice GE. Glycerophospholipid metabolism and human labour. Reprod Fertil Dev. 1995;7:613-622.
26. 2 and prostaglandin H synthase-2 by interleukin-1β in WISH cells is inhibited by dexamethasone. Prostaglandis. 1996;51:107-124.
27. 2 in human amnion at parturition. J Soc Gynecol Invest. 1996;3:100 Abstract.
28. Teixeira FJ, Zakar T, Hirst J, et al. Prostaglandin endoperoxide- H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation,at tem, and during labor. J Clin Endocrinol Metab. 1994;78:1396-1402.
29. Slater DM, Berger LC, Newton R, et al. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol. 1995;172:77-82.
30. Hirst JJ, Teixeira FJ, Zakar T, et al. Prostaglandin endoeroxide-synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab. 1995;80:517-523.
31. Mijovic JE, Hirst JJ, Zakar T, et al. PGHS- 1 and -2 expression and activity during ges- tation amd at term in human chorion and decidua. Placenta. 1996;17:Abstract 40.
32. Morham SG, Langenbach R, Loftin CD, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995;83:472-482.
33. Wiqvist N. The use of inhibitors of prostaglandin synthesis in obstetrics. In: Keirse MJNC, Anderson ABM, Bennebrock-Gravenhorst J, eds. Human Parturition. The Hague: Martinus Nijhoff, 1979:189-200.
34. Pilbeam CC, Raisz LG, Voznesensky O, et al. Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins. J Bone Min Res. 1995;10:406-414.
35. Van den Veyver IB, Moise KJ, Jr. Prostaglandin synthetase inhibitors in pregnance. Obstet Gynecol Survey. 1993;48:493-502.
36. Kniss DA, Zimmerman PD, Gabbe SG, et al. Selective ablation of cyclooxygenase-2 gene expression and prostaglandin biosynthesis by antisense phosphorothionates. J Soc Gyn Invest. 1996;3:95 Abstact.
37. Angle M, Maki N, Johnston JM. Bioactive metabolites of glycerophopholipid metab- olism in elation to parturition. In: The Onset of Labour: Cellular and Integrative Mechanisms, McNellis D, MacDonald PC, Challis JRG, et al, eds. New York: Perinatology Press, 1988:125-138.
38. Narahara H, Tanaka Y, Kawako Y, et al. Cytokine-modulation of platelet-activating factor metabolism in human decidua during parturition. Placenta. 1996;17:A36.
39. Thorburn GD, Challis JRG. Endocrine control of parturition . Physiol Rev. 1979;59:863-917.
40. Lewis PR, Galvin PM, Short RV. Salivary oestriol and progesterone concentrations in women during late pregnancy, parturition, and thepuerperium. J Endocrinol. 1987;115:177-181.
41. Mitchell BF, Challis JRG. Estrogen and progesterone metabolism in human fetal membranes. In: Mitchell BF, ed. The Physiology and Biochemistry of Human Fetal Membranes. New York: Perinatology Press, 1988:5-28.
42. Mazor M, Hershkovitz R, Chaim W, et al. Human preterm birth is associated with systemic and local changes in progesterone/ 17β-estradiol ratios. Am J Obstet Gynecol. 1994:171:231-236.
43. Karimu A, Wong S, Mitchell BF. Changes in the expression of estrogen and progesterone receptors with gestation in human decidua: a quantitative study. Placenta. 1996;17:Abstract 22.
44. Parker CR Jr, Illingworth DR, Bissonette J, et al. Endocrine changes during pregnancy in a patient with homozygous familial hypobetalipoproteinemia. N Engl J Med. 1986;314:557-560.
45. Shozu M, AKasofu K, Harada T, et al. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab. 1991;72:560-566.
46. Ballabio A, Shapiro LJ. Steoid sulfatase deficiency and X-linked ichthyosis.In: Scriver CR, Beaudet AL, Sly WS, et al. eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. Chap. 11. New York : McGraw Hill, 1994:2999-3022.
47. Keirse MJNC. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol. 1990;97:149-154.
48. Erny R, Pigne A, Prouvost C, et al. The effects of oral asministration of progesterone for premature labour. Am J Obstet Gynecol. 1996;154:525-529.
49. Noblot G, Audra P, Dargent D, et al. The use of micronized progesterone in the treatment of menance of preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1991;40:203-209.
50. Gibbs RS, Romero R, Hillier SL, et al. A review of pemature birth and subclinical infection. Am J Obstet Gynecol. 1992;166:1515-1528.
51. Romero R, Munoz H, Gomez R, et al. Does infection premature labour and delivery? Semin Reprod Endocrinol. 1994;12:227-239.
52. Dudley DJ, Trautman MS. Infection, inflammation, and contractions: the role of cytokines in the pathophysiology of pretem labour. Semin Reprod Endocrinol. 1994;12:263-272.
53. Fidel PL, Romero R, Wolf N, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol. 1994;170:1467-1475.
54. Hirsch E, Saotome I, Hirsch D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol. 1995;172:1598-1603.
55. Gravett MG, Witkin SS, Novy MJ. A non-human primate model for chorioamnionitis and preterm labour. Semin Reprod Endocrinol. 1994;12:246-262.
56. Baggia S, Gravett MG, Witkin SS, et al. Interleukin-1β intra-amniotic infusion induces tumour necrosis factor-α,prostaglan- din production and preterm contractions in pregnant rhesus monkeys. J Soc Gynecol Invest. 1996;3:121-126.
57. Dudley DJ, Dangerfield A, Edwin SS. Interleukin-10 (IL-10) prevents peterm birth in a mouse model of infection-mediated preterm labor. J Soc Gynecol Invest. 1996;3:67 Abstract.
58. Kent AS, Sullivan MH, Elder MG. Transfer of cytokines through human fetal membanes. J Reprod Fertil. 1994;100:81-84.
59. Stallmach T, Hebisch G, Joller-Jemelka, et al. Cytokine production and visualized effects in the feto-maternal unit. Lab Invest. 1995;73:384-392.
60. Saito S, Kashara T, Kato Y, et al. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine. 1993;5:81-88.
61. Opsjon SL, Wathen NC, Tingulstad S, et al. Tumour necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy Am J Obstet Gynecol. 1993;169:397-404.
62. Lockwood CJ. The diagnosis of preterm labour and the prediction of preterm delivery. Clin Obstet Gynecol. 1995;38:675-687.
63. Mitchell MD, Edwin SS, Silver RM, et al. Potential agonist of the interleukin-1 receptor antagonist protein: implications for treatment of women. J Clin Endocrinol Metab. 1993;76:1386-1388.
64. Dudley DJ, Chen CL, Mitchell MD, et al. Potential role(s) of interleukin-10 (IL-10) during pregnancy. Ann Meeting Soc Gynecol Invest. 1993;P77.
65. Keelan JA, Drew A, Sato T, et al. Interleukin-10 has opposing actions on cytokine production in amnion and choriodecidual explants. J Soc Gynecol Invest 1997;4:l67 Abstract.
66. Goodwin TM, Valenzuela G, Silver H, et al. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol. 1996;13:143-146.
67. Challis JRG, Matthews SG Van Meir C, et al. Current topic: the placental corticotrophin axis. Placenta. 1995;16:481-502.
68. Margioris AN. Corticotropin-releasing hormone and pro-opiomelanocortin in placenta and fetal membrranes. In: Molecular Aspects of Placental and Fetal Membrane Autacoids, London: CRC Press 1993;277-294.
69. Mastorakos G, Scopa CD, Kao LC, et al. Pesence of immunoreactive corticotropin- releasing hormone in human endometrium. J Clin Endocrinol Metab. 1996;81:1046-1050.
70. Petraglia F, Potter E, Cameon VA, et al. Corticotropin-releasing factor binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab. 1993;77:919-924.
71. Linton EA, Perkins AV, Woods RJ, et al. Corticotropin-releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab. 1993;76:260-262.
72. Behan DP, Khongsaly O, Liu XJ, et al. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsobant assay. J Clin Endocrinol Metab. 1996;81:2579-2586.
73. Vamkapoulos NC, Chrousos GP. Hormonal regulation of human corticotropin- releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev. 1994; 15:409-420.
74. Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nature Med. 1996;2:556-660.
75. Novy MJ, Walsh SW. Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obset Gynecol. 1983;145:920-932.
76. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats produces signs similar to those of preeclampsia . Am J Obstet Gynecol. 1993;169:1316-1320.
77. o-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol. 1996;175:207-212.
78. Bansal RK, Goldsmith PC, Zaloudek CJ, et al. Effects of pregnancy and labour on inducible nitric oxide synthase in human myometrium. J Soc Gynecol Invest. 1996;3:97 Abstract.
79. Lees C, Campbell S, Jauniaux E, et al. Arrest of preterm labour and prolongation of gestation with gluceryl trinitrate, a nitric oxide donor. Lancet. 1994;343:1325-1326.
80. Shew RL, Yee JA, Kliewer DB et al. Parathyroid homone-related peptide inhibits stimulated uterine contrations in vitro. J Bone Min Res. 1991;6:955-959.
81. Mitchell MD, Hunter C, Dudley DJ, et al. Significant decrease in parathyroid hormone-related protein concentrations in am- niotic fluid with labour at term but not preterm. Reprod Fertil Dev. 1996;8:231-234.
82. Hill WC. Risks and complications of tocolysis. Clin Obstet Gynecol. 1995;38:725-745.
83. How HY, Hughes SA, Vogel RL, et al. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol. 1995;173:1518-1522.